(GSK ARIOS) follow-Up study to assess Long-Term safety and outcomes in infants and children born to mothers participating in Retosiban Treatment Studies

Project: Research project

Project Details

StatusFinished
Effective start/end date9/16/16 → 9/15/18

Funding

  • GlaxoSmithKline Pharmaceuticals: $4,000.00